REGISTERED NUMBER: 15921838 (England and Wales)

Unaudited Financial Statements

for the Period 28 August 2024 to 31 December 2025

for

Haemanalytica Ltd

Page

Balance Sheet

1

CURRENT ASSETS

153,204

CREDITORS

Amounts falling due within one year

(47,163

)

NET CURRENT ASSETS

106,041

TOTAL ASSETS LESS CURRENT LIABILITIES

106,041

CAPITAL AND RESERVES

106,041

NOTES TO THE FINANCIAL STATEMENTS

1.	STATUTORY INFORMATION

Haemanalytica Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

15921838

Registered office:

C/o Hcr Law Aquis House

49-51 Blagrave Street

Reading

United Kingdom

RG1 1PL

The presentation currency of the financial statements is the Pound Sterling (£).

2.	GOING CONCERN

The Company is considered a Going Concern as it continues to have the support of the Directors for a period of at least 12 months from the date of these accounts being approved.

3.	AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the period was 3 .

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 December 2025.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 December 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 20 May 2026 and were signed on its behalf by:

Dr W Kilgallon - Director

Dr J D Rowson - Director